+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Viscosupplementation - Global Strategic Business Report

  • PDF Icon

    Report

  • 196 Pages
  • November 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5140110
The global market for Viscosupplementation was estimated at US$5.2 Billion in 2023 and is projected to reach US$8.8 Billion by 2030, growing at a CAGR of 7.8% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Single Injection Viscosupplementation segment, which is expected to reach US$4.9 Billion by 2030 with a CAGR of a 8.5%. The Three Injection Viscosupplementation segment is also set to grow at 7.3% CAGR for the next 7-year period.
  • Regional Analysis: Gain insights into the U.S. market, estimated at $1.4 Billion in 2023, and China, forecasted to grow at an impressive 11.6% CAGR to reach $2.2 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Viscosupplementation Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Viscosupplementation Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Viscosupplementation Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players such as Allergan PLC, Anika Therapeutics SRL, Contipro a.s., and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 46 Featured):

  • Allergan PLC
  • Anika Therapeutics SRL
  • Contipro a.s.
  • DePuy Synthes
  • F. Hoffmann-La Roche AG
  • Ferring Pharmaceuticals, Inc.
  • Galderma SA
  • Lifecore Biomedical LLC
  • Merz Aesthetics
  • Mylan Pharmaceutical Pvt. Ltd.
  • Nordic Drugs
  • Sanofi SA
  • Shanghai Jingfeng Pharmaceutical Co., Ltd
  • Smith & Nephew PLC
  • TRB Chemedica International SA

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Viscosupplementation - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • Global Economic Update
2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Recent Past, Current & Future Analysis for Viscosupplementation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 2: World Historic Review for Viscosupplementation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 3: World 16-Year Perspective for Viscosupplementation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
  • TABLE 4: World Recent Past, Current & Future Analysis for Single Injection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 5: World Historic Review for Single Injection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 6: World 16-Year Perspective for Single Injection by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 7: World Recent Past, Current & Future Analysis for Three Injection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 8: World Historic Review for Three Injection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 9: World 16-Year Perspective for Three Injection by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 10: World Recent Past, Current & Future Analysis for Five Injection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 11: World Historic Review for Five Injection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 12: World 16-Year Perspective for Five Injection by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 13: World Viscosupplementation Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
III. MARKET ANALYSIS
UNITED STATES
  • Viscosupplementation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • TABLE 14: USA Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 15: USA Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 16: USA 16-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2014, 2024 & 2030
CANADA
  • TABLE 17: Canada Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 18: Canada Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 19: Canada 16-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2014, 2024 & 2030
JAPAN
  • Viscosupplementation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • TABLE 20: Japan Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 21: Japan Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 22: Japan 16-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2014, 2024 & 2030
CHINA
  • Viscosupplementation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • TABLE 23: China Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 24: China Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 25: China 16-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2014, 2024 & 2030
EUROPE
  • Viscosupplementation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • TABLE 26: Europe Recent Past, Current & Future Analysis for Viscosupplementation by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 27: Europe Historic Review for Viscosupplementation by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 28: Europe 16-Year Perspective for Viscosupplementation by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
  • TABLE 29: Europe Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 30: Europe Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 31: Europe 16-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2014, 2024 & 2030
FRANCE
  • Viscosupplementation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • TABLE 32: France Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 33: France Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 34: France 16-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2014, 2024 & 2030
GERMANY
  • Viscosupplementation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • TABLE 35: Germany Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 36: Germany Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 37: Germany 16-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2014, 2024 & 2030
ITALY
  • TABLE 38: Italy Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 39: Italy Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 40: Italy 16-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2014, 2024 & 2030
UNITED KINGDOM
  • Viscosupplementation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • TABLE 41: UK Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 42: UK Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 43: UK 16-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2014, 2024 & 2030
SPAIN
  • TABLE 44: Spain Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 45: Spain Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 46: Spain 16-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2014, 2024 & 2030
RUSSIA
  • TABLE 47: Russia Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 48: Russia Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 49: Russia 16-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2014, 2024 & 2030
REST OF EUROPE
  • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 51: Rest of Europe Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 52: Rest of Europe 16-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2014, 2024 & 2030
ASIA-PACIFIC
  • Viscosupplementation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Viscosupplementation by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 54: Asia-Pacific Historic Review for Viscosupplementation by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 55: Asia-Pacific 16-Year Perspective for Viscosupplementation by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
  • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 57: Asia-Pacific Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 58: Asia-Pacific 16-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2014, 2024 & 2030
AUSTRALIA
  • Viscosupplementation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
  • TABLE 59: Australia Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 60: Australia Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 61: Australia 16-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2014, 2024 & 2030
INDIA
  • Viscosupplementation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
  • TABLE 62: India Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 63: India Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 64: India 16-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2014, 2024 & 2030
SOUTH KOREA
  • TABLE 65: South Korea Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 66: South Korea Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 67: South Korea 16-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2014, 2024 & 2030
REST OF ASIA-PACIFIC
  • TABLE 68: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 69: Rest of Asia-Pacific Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 70: Rest of Asia-Pacific 16-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2014, 2024 & 2030
LATIN AMERICA
  • Viscosupplementation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
  • TABLE 71: Latin America Recent Past, Current & Future Analysis for Viscosupplementation by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 72: Latin America Historic Review for Viscosupplementation by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 73: Latin America 16-Year Perspective for Viscosupplementation by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
  • TABLE 74: Latin America Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 75: Latin America Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 76: Latin America 16-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2014, 2024 & 2030
ARGENTINA
  • TABLE 77: Argentina Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 78: Argentina Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 79: Argentina 16-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2014, 2024 & 2030
BRAZIL
  • TABLE 80: Brazil Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 81: Brazil Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 82: Brazil 16-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2014, 2024 & 2030
MEXICO
  • TABLE 83: Mexico Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 84: Mexico Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 85: Mexico 16-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2014, 2024 & 2030
REST OF LATIN AMERICA
  • TABLE 86: Rest of Latin America Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 87: Rest of Latin America Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 88: Rest of Latin America 16-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2014, 2024 & 2030
MIDDLE EAST
  • Viscosupplementation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
  • TABLE 89: Middle East Recent Past, Current & Future Analysis for Viscosupplementation by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 90: Middle East Historic Review for Viscosupplementation by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 91: Middle East 16-Year Perspective for Viscosupplementation by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
  • TABLE 92: Middle East Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 93: Middle East Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 94: Middle East 16-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2014, 2024 & 2030
IRAN
  • TABLE 95: Iran Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 96: Iran Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 97: Iran 16-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2014, 2024 & 2030
ISRAEL
  • TABLE 98: Israel Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 99: Israel Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 100: Israel 16-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2014, 2024 & 2030
SAUDI ARABIA
  • TABLE 101: Saudi Arabia Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 102: Saudi Arabia Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 103: Saudi Arabia 16-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2014, 2024 & 2030
UNITED ARAB EMIRATES
  • TABLE 104: UAE Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 105: UAE Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 106: UAE 16-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2014, 2024 & 2030
REST OF MIDDLE EAST
  • TABLE 107: Rest of Middle East Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 108: Rest of Middle East Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 109: Rest of Middle East 16-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2014, 2024 & 2030
AFRICA
  • Viscosupplementation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
  • TABLE 110: Africa Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 111: Africa Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 112: Africa 16-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2014, 2024 & 2030
IV. COMPETITION

Companies Mentioned

  • Allergan PLC
  • Anika Therapeutics SRL
  • Contipro a.s.
  • DePuy Synthes
  • F. Hoffmann-La Roche AG
  • Ferring Pharmaceuticals, Inc.
  • Galderma SA
  • Lifecore Biomedical LLC
  • Merz Aesthetics
  • Mylan Pharmaceutical Pvt. Ltd.
  • Nordic Drugs
  • Sanofi SA
  • Shanghai Jingfeng Pharmaceutical Co., Ltd
  • Smith & Nephew PLC
  • TRB Chemedica International SA

Table Information